NextGen Biomed Ltd. Logo

NextGen Biomed Ltd.

NXGN | TA

Overview

Corporate Details

ISIN(s):
IL0010839301
LEI:
Country:
Israel
Address:
132 Azrieli Towers Round Building Menachem Begin Street P.O. Box 14, 6701101 Tel Aviv
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

NextGen Biomed Ltd. is a research and development company operating in the biotechnology and medical device sectors. The company focuses on developing products such as the EyePen, an injection module designed for individuals with diabetes to monitor insulin dosage and timing. Its portfolio also includes pain-free auto-injectors, lancet devices, and the development of topical treatments for conditions like psoriasis. The company was formerly known as Sela Group.Com Ltd.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for NextGen Biomed Ltd.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2024-06-30 18:01
Regulatory News Service
Trading in the company's shares (ISIN IL0010839301) will be renewed on Tuesday,…
Hebrew (modern) 158.5 KB
2024-05-01 10:36
Regulatory News Service
Trading in the company's shares has been suspended since the company has not ye…
Hebrew (modern) 78.8 KB
2024-04-18 19:36
Regulatory News Service
Suspension of trade due to failure in publishing financial reports-Notification
Hebrew (modern) 129.9 KB
2021-01-12 18:34
Regulatory News Service
On January 14, 2021, the company's securities will be transferred from the main…
Hebrew (modern) 251.9 KB

Automate Your Workflow. Get a real-time feed of all NextGen Biomed Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for NextGen Biomed Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN